Scientific Resources
Search our resources — articles, case studies, presentations, and more — for answers to your biggest assay inquiries and drug discovery questions.
Presentation
SLAS2026 Solutions Spotlight
Listen to Founder and CEO Zack Gurard-Levin creatively present Peapod Bio’s assay development and high-throughput screening capabilities along with its world-class screening collection and unique solutions that utilize surface chemistry to detect previously undetectable analytes using MALDI mass spectrometry.
All Peapod Bio Resources
Sort by Type
Search Resources
-
From Prediction to Proof: Why AI/ML Drug Discovery Still Needs Experimental Data
Artificial intelligence, machine learning, and large language models (collectively referred to here as “AI/ML”) are genuinely reshaping how scientists imagine, prioritize, and advance new therapies. The promise of AI/ML is ubiquitous. We constantly see headlines touting how AI/ML will compress years of drug discovery into months and reduce the costs of identifying new therapies. However,
-
Assay development and high-throughput screen for Sortase A inhibitors using an innovative mass spectrometry platform to combat antibiotic resistant bacteria.
Abstract: Bacterial virulence is a driving mechanism of infection and disease. In Methicillin-sensitive and -resistant Staphylococcus aureus (MRSSA/MRSA), Sortase A plays a crucial role in bacterial virulence, where its transpeptidase activity anchors specific proteins like Staphylococcal protein A (SpA) to the cell wall enabling colonization and infection as well as facilitating resistance to antibiotics. Sortase
-
SLAS2026 Solutions Spotlight
Listen to Founder and CEO Zack Gurard-Levin creatively present Peapod Bio’s assay development and high-throughput screening capabilities along with its world-class screening collection and unique solutions that utilize surface chemistry to detect previously undetectable analytes using MALDI mass spectrometry.
-
Three trends from SLAS2026 shaping assay development and HTS
While the life sciences community continues to process what we learned at the record-breaking SLAS2026 conference in Boston, it’s clear that assay development and high-throughput screening (HTS) are at an inflection point. Novel technologies, emerging biological questions, and new expectations for speed and decision-making are reshaping how we think about screening for small molecule drug
-
World class compound libraries and assays rapidly identify promising drug leads
Learn how Peapod Bio’s world-class collection of small molecules is launching drug discovery programs for even the most challenging targets.
-
Get your head out of your assay!
Introducing a new web series from Peapod Bio! In this series, CEO Zachary Gurard-Levin, PhD talks about the nuances of developing robust assays for small molecule drug discovery. He speaks with other assay experts about critical factors to consider that often extend beyond the assay well and protocol. Stay tuned every two weeks for new
Explore Peapod Bio Solutions
Assay
Development
High-Throughput
Screening
Affinity Selection
Mass Spectrometry
Small Molecule Libraries
Ready to generate results?